RAPT Therapeutics, Inc. Recorded Big Gain
Tue, Jan 20, 2026 at 07:15 PM
RAPT Therapeutics, Inc. (RAPT:NASDAQ) shot up at $57.57, representing a gain of 64%. On Tue, Jan 20, 2026, RAPT:NASDAQ hit a New 2-Week High of $57.57. The stock appeared on our News Catalysts scanner on Tue, Jan 20, 2026 at 02:24 PM in the 'ACQUISITION' category. From Tue, Jan 06, 2026, the stock recorded 66.67% Up Days and 70.00% Green Days
About RAPT Therapeutics, Inc. (RAPT:NASDAQ)
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Top 10 Gainers:
- INVO Fertility, Inc. (IVF:NASDAQ), 191.73%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 165.96%
- Pheton Holdings Ltd (PTHL:NASDAQ), 105.16%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 69.08%
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 64.02%
- Signing Day Sports, Inc. (SGN:NYSEMKT), 61%
- Youlife Group Inc. (YOUL:NASDAQ), 59.93%
- Top Wealth Group Holding Limited (TWG:NASDAQ), 54.31%
- Lulu's Fashion Lounge Holdings, Inc. (LVLU:NASDAQ), 42.28%
- Lottery.com Inc. (SEGG:NASDAQ), 42.19%